This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Centre National De La Recherche Scientifique, Chu Nantes, National Institute of Health and Medical Research. Active years: 2024.
Company Filing History:
1 out of 5,383 
1 out of 18 
1 out of 1,853 
Years Active: 2024
Title: Maxime Gueguinou: Innovator in Cancer Treatment
Introduction
Maxime Gueguinou is a notable inventor based in Tours, France. He has made significant contributions to the field of cancer treatment through his innovative research and development of new compounds.
Latest Patents
Maxime Gueguinou holds a patent for "Ion channel inhibitor compounds for cancer treatment." This invention concerns a compound of the following general formula (I), which aims to provide new therapeutic options for cancer patients.
Career Highlights
Throughout his career, Gueguinou has worked with prestigious institutions such as the Centre National De La Recherche Scientifique and the Université d'Orléans. His work has focused on advancing scientific knowledge and developing practical applications in medicine.
Collaborations
Maxime has collaborated with notable colleagues, including Sylvain Routier and Frédéric Buron, to further enhance his research efforts and contribute to the scientific community.
Conclusion
Maxime Gueguinou's work in developing ion channel inhibitor compounds represents a significant advancement in cancer treatment. His dedication to research and collaboration with esteemed institutions and colleagues highlights his commitment to improving healthcare outcomes.